Page 5 - ஜோசப் ஸ்க்வார்ட்ஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஜோசப் ஸ்க்வார்ட்ஸ். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஜோசப் ஸ்க்வார்ட்ஸ் Today - Breaking & Trending Today

Sarepta Therapeutics (SRPT) Q1 2021 Earnings Call Transcript

Sarepta Therapeutics (SRPT) Q1 2021 Earnings Call Transcript
Motley Fool Transcribing
© The Motley Fool
Logo of jester cap with thought bubble.
Sarepta Therapeutics (NASDAQ: SRPT)
Good afternoon, ladies and gentlemen, and welcome to the Sarepta Therapeutics first-quarter 2021 earnings call. [Operator instructions] As a reminder, today s program is being recorded. I d now like to introduce your host for today s program, Mary Jenkins, senior management, investor relations. Please go ahead.
Mary Jenkins
Senior Management, Investor Relations
Thank you, Jonathan, and thank you all for joining today s call. Earlier today, we released our financial results for the first-quarter 2021. The press release is available on our website at sarepta.com, and our 10-Q was filed with the Securities and Exchange Commission earlier this afternoon. Joining us on the call today are Doug Ingram, Ian Estepan, Dallan Murray, Dr. ....

United States , Anupam Rama , Raymond James , Louise Rodino , Gena Wang , Mary Jenkins , Anvita Gupta , Louise Rodino Klapac , Alethia Young , Brian Abrahams , Ian Estepan , Salveen Richter , Doug Ingram , Gil Blum , America Merrill Lynch , Danielle Brill , Tim Lugo William Blair , Daniil Gataulin Raymond James , Kelly Girskis , Sonya Bhatia Goldman Sachs , Brian Skorney , Tim Lugo , Gilmore Oneill , Anvita Gupta Cowen , Colin Bristow , Tazeen Ahmad ,

Arena Pharmaceuticals Inc (ARNA) Q1 2021 Earnings Call Transcript

Good day, everyone, and welcome to Arena Pharmaceuticals Corporate Conference Call. [Operator Instructions]
I will now turn the call over to Mr. Patrick Malloy, Vice President, Investor Relations at Arena Pharmaceuticals. Please go ahead, sir.
Patrick Malloy
Vice President, Investor Relations and Corporate Communications
Great. Thank you, Delfin, and good afternoon, everyone. Thanks for joining us today, and we hope you had a chance to review the press release we issued this afternoon announcing our first quarter 2021 financial results. Joining me on today s call are Amit Munshi, our President and Chief Executive Officer; and Laurie Stelzer, our Chief Financial Officer. ....

United States , Patrick Malloy , Jessica Fye Jpmorgan , Amit Munshi , Nina Cantor Fitzgerald , Jason Gerberry , Jessica Fye , Alethia Young , Kennen Mackay , Laurie Stelzer , Amitd Munshi , Joseph Schwartz , Arena Pharmaceuticals Corporate Conference Call , Arena Pharmaceuticals Inc , Cantor Fitzgerald , Corporate Communications , Investor Relations At Arena Pharmaceuticals , Chi Meng Fong Bank , Arena Pharmaceuticals Corporate Conference , Vice President , Investor Relations , Chief Executive Officer , Chief Financial , Chief Executive , ஒன்றுபட்டது மாநிலங்களில் , பேட்ரிக் மலாய் ,

DMD | Benzinga

Just weeks into its life as a publicly traded company, Solid Biosciences Inc (NASDAQ: SLDB) caught the eyes of four analysts who assumed coverage Tuesday with a mix of Holds and Buys.
Here is what one of the more bearish critics had to say.
The Rating
Goldman Sachs analyst Salveen Richter. Read More. ....

Adam Feuerstein , Goldman Sachs , Yun Zhong , Pharma Emflaza , Debjit Chattopadhyay , Sarepta Exondys , Leerink Joseph Schwartz , Alethia Young , Brian Abrahams , Salveen Richter , Joseph Schwartz , Doug Ingram , Goldman Sachs Gets Firm On Solid Biosciencestuesday , Why Wave Life Sciences Valuation Is Falling , Wave Life Sciences Ltd , Credit Suisse , Drug Administration , Marathon Pharmaceuticals , Sarepta Therapeutics Inc , Solid Biosciences Inc , Health Care , Wave Life Sciences , Duchenne Muscular Dystrophy , Dosing Of Sarepta , Next Gen Eteplirsen Can Potentially Achieve Over , Therapeutics Inc ,

Biomarin Pharmaceutical Inc (BMRN) Q1 2021 Earnings Call Transcript

BMRN earnings call for the period ending March 31, 2021. ....

United States , Saudi Arabia , Hank Fuchs , Cory Kasimov , Henryj Fuchs , Gena Wang , Mohit Bansal Citigroup , Paul Matteis Stifel , Elizabeth Webster Goldman Sachs , Chris Raymond Piper Sandler , Gena Wang Barclays , Salveen Richter , Geoff Meacham , Tony Rodriguez Cowen , Kostas Biliouris Morgan Stanley , Piper Sandler , Brianr Mueller , Srikripa Devarakonda Truist , Jeff Ajer , Dave Jacoby , Phil Nadeau , Mohit Bansal , Traci Mccarty , William Blair , Robyn Karnauskas , Kevin Eggan ,

Reata Pharmaceuticals (RETA) Receives a Buy from Leerink Partners

Markets
Leerink Partners analyst Joseph Schwartz maintained a Buy rating on Reata Pharmaceuticals (RETA – Research Report) on April 26. The company’s shares closed last Wednesday at $103.79.
According to TipRanks.com, Schwartz is a 5-star analyst with an average return of 15.9% and a 49.6% success rate. Schwartz covers the Healthcare sector, focusing on stocks such as Applied Molecular Transport, Ultragenyx Pharmaceutical, and Crinetics Pharmaceuticals.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Reata Pharmaceuticals with a $186.33 average price target, implying an 82.4% upside from current levels. In a report issued on April 26, Barclays also initiated coverage with a Buy rating on the stock with a $155.00 price target. ....

W Christian Wigley , Philipj Thomas , Joseph Schwartz , Jonathanm Graff , Reata Pharmaceuticals , Reata Pharmaceuticals Inc , Research Report On , Crinetics Pharmaceuticals , Leerink Partners , Research Report , Applied Molecular Transport , Ultragenyx Pharmaceutical , Strong Buy , Waldemar Priebe , Jef Karel De Brabander , ஜோசப் ஸ்க்வார்ட்ஸ் , றேதத மருந்துகள் , றேதத மருந்துகள் இன்க் , ஆராய்ச்சி அறிக்கை ஆன் , கிரினெடிக்ஸ் மருந்துகள் , ஆராய்ச்சி அறிக்கை , பயன்படுத்தப்பட்டது மூலக்கூறு போக்குவரத்து , வலுவான வாங்க , வால்டேமர் ப்ரிஎபே ,